Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material.
暂无分享,去创建一个
Jing Chen | Gary Eichenbaum | Wei-Guo Dai | Crystal Pollock-Dove | Liang C Dong | L. Dong | Paul Mansky | G. Eichenbaum | Wei-guo Dai | P. Mansky | Shu Li | C. Pollock-Dove | Shu Li | Jing Chen
[1] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[2] C. Ho,et al. N-GLUCURONIDATION OF THE PLATELET-DERIVED GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR 6,7-(DIMETHOXY-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)-(3-FLUORO-PHENYL)-AMINE BY HUMAN UDP-GLUCURONOSYLTRANSFERASES , 2006, Drug Metabolism and Disposition.
[3] E. Kerns,et al. High throughput physicochemical profiling for drug discovery. , 2001, Journal of pharmaceutical sciences.
[4] B. Faller,et al. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.
[5] Chris McNulty,et al. A High-Throughput Combinatorial Approach for the Discovery of a Cremophor EL-Free Paclitaxel Formulation , 2003, Pharmaceutical Research.
[6] Li Di,et al. High throughput artificial membrane permeability assay for blood-brain barrier. , 2003, European journal of medicinal chemistry.
[7] Michael J Cima,et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.
[8] D. Thakker,et al. High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism. , 2004, Journal of pharmaceutical sciences.
[9] G. Levy,et al. Pharmacokinetics of salicylamide elimination in man. , 1967, The Journal of pharmacology and experimental therapeutics.
[10] C. Bevan,et al. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.
[11] M. Abe,et al. Solubilization of 2-phenylethanol in surfactant vesicles and micelles , 1993 .
[12] R. Strickley. Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.
[13] Samir Mitragotri,et al. Discovery of transdermal penetration enhancers by high-throughput screening , 2004, Nature Biotechnology.
[14] Yung-Hsiang Chen,et al. Semi-automatic high-throughput determination of plasma protein binding using a 96-well plate filtrate assembly and fast liquid chromatography-tandem mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[15] R. Morrison,et al. Higher-throughput screening for Caco-2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry system. , 2003, Rapid communications in mass spectrometry : RCM.
[16] Mark C Manning,et al. High throughput formulation: strategies for rapid development of stable protein products. , 2002, Pharmaceutical biotechnology.
[17] B. Müller,et al. Solubility and stability of lorazepam in bile salt/soya phosphatidylcholine-mixed micelles. , 1999, Drug development and industrial pharmacy.
[18] Samir Mitragotri,et al. High Throughput Screening of Transdermal Formulations , 2002, Pharmaceutical Research.
[19] Alexander V Kabanov,et al. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[20] J. Collett,et al. Interaction of substituted benzoic acids with polysorbate 20 micelles. , 1975, Journal of pharmaceutical sciences.
[21] K Gubernator,et al. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.
[22] C. Pouton,et al. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Beate Bittner,et al. Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters. , 2002, Current opinion in drug discovery & development.
[24] Mahesh Chaubal. Application of formulation technologies in lead candidate selection and optimization , 2004 .
[25] Samuel H. Yalkowsky,et al. Solubility and Solubilization in Aqueous Media , 1999 .
[26] Ping Gao,et al. Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations , 2004, Drug development and industrial pharmacy.
[27] C. Kohlsdorfer,et al. High-throughput determination of the free fraction of drugs strongly bound to plasma proteins. , 2004, Journal of pharmaceutical sciences.
[28] M. F. Saettone,et al. Solubilization of tropicamide by poloxamers: physicochemical data and activity data in rabbits and humans , 1988 .
[29] Alex Avdeef,et al. Physicochemical Profiling (Solubility, Permeability and Charge State) , 2001 .
[30] O. Hänninen. Mucosal biotransformation of toxins in the gut. , 1985, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[31] M. Gouda,et al. Micellar solubilization of barbiturates. I. Solubilities of certain barbiturates in polysorbates of varying hydrophobic chain length. , 1970, Journal of pharmaceutical sciences.
[32] Jian Li,et al. (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells. , 2005, Journal of medicinal chemistry.